M. Enomoto

发表

Expression of 5-lipoxygenase in human colorectal cancer.

M. Yasuno, S. Iida, K. Sugihara, 2006, World journal of gastroenterology.

Discontinuous Rectal Cancer Spread in the Mesorectum and the Optimal Distal Clearance Margin in Situ

K. Sugihara, M. Enomoto, C. Ono, 2002, Diseases of the colon and rectum.

Optimal Follow-up of Stage I Colorectal Cancer Patients

K. Sugihara, T. Higuchi, M. Enomoto, 2006 .

Methylated BNIP3 gene in colorectal cancer prognosis.

S. Iida, K. Sugihara, Hiroshi Tanaka, 2010, Oncology letters.

Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D constructive interference in steady-state MR imaging.

I. Yamada, S. Okabe, J. Kumagai, 2008, Radiology.

Cyclooxygenase-2 Expression

K. Sugihara, H. Uetake, Labile Togba Soumaoro, 2004, Clinical Cancer Research.

Clinical significance of UNC 5 B expression in colorectal cancer

S. Okazaki, S. Iida, K. Sugihara, 2022 .

Cyclooxygenase-2 Expression : A Significant Prognostic Indicator for Patients With Colorectal Cancer Labile

K. Sugihara, H. Uetake, Y. Takagi, 2004 .

Coexpression of VEGF-C and Cox-2 in Human Colorectal Cancer and its Association With Lymph Node Metastasis

M. Yasuno, S. Iida, K. Sugihara, 2006, Diseases of the colon and rectum.

Case Report of a Patient with Perforation of Transverse and Ascending Colon Diverticulum and Bleeding of Cecal Diverticulum

M. Yasuno, S. Iida, K. Sugihara, 2009 .

Cyclooxygenase-2 expression and its relationship with proliferation of colorectal adenomas.

S. Okabe, K. Sugihara, T. Higuchi, 2003, Japanese journal of clinical oncology.

Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis.

M. Yasuno, S. Iida, K. Sugihara, 2011, Oncology reports.

PIK3CA mutation and methylation influences the outcome of colorectal cancer.

S. Iida, K. Sugihara, H. Uetake, 2012, Oncology letters.

Cyclooxygenase-2 Expression in Colorectal Adenomas

S. Okabe, K. Sugihara, M. Enomoto, 2003, Diseases of the colon and rectum.

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

M. Yasuno, S. Iida, K. Sugihara, 2007, International journal of cancer.

Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis.

H. Lenz, K. Danenberg, P. Danenberg, 2009, International journal of oncology.

Clinical Significance of Lymph Node Ratio and Location of Nodal Involvement in Patients with Right Colon Cancer

S. Iida, K. Sugihara, H. Uetake, 2011, Digestive Surgery.

Messenger RNA Expression of Vascular Endothelial Growth Factor and Its Receptors in Primary Colorectal Cancer and Corresponding Liver Metastasis

H. Lenz, K. Danenberg, P. Danenberg, 2008, Annals of Surgical Oncology.

A Case of Perineal Rhabdomyosarcoma

T. Nemoto, K. Sugihara, H. Uetake, 1998 .

JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats

K. Sugihara, H. Uetake, T. Higuchi, 2005, BMC Cancer.

Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15

Kenichi Sugihara, Masayuki Enomoto, Shinji Morita, 2007, Annals of Surgical Oncology.

Validation and Clinical Use of the Japanese Classification of Colorectal Carcinomatosis: Benefit of Surgical Cytoreduction Even without Hyperthermic Intraperitoneal Chemotherapy

S. Iida, K. Sugihara, H. Uetake, 2010, Digestive Surgery.

Clinical significance of UNC5B expression in colorectal cancer.

Hiroshi Tanaka, Hiroshi Mizushima, Kenichi Sugihara, 2011, International journal of oncology.

The effect of meloxicam, a selective COX-2 inhibitor, on the microvasculature of small metastatic liver tumors in rats.

K. Sugihara, H. Uetake, T. Higuchi, 2007, Japanese journal of clinical oncology.

JTE‐522, a selective COX‐2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: A vascular cast model study

K. Sugihara, H. Uetake, T. Higuchi, 2004, International journal of cancer.

A Study of Obstructive Colorectal Cancer.

K. Sugihara, M. Enomoto, K. Yoshinaga, 2000 .

Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.

M. Fukayama, T. Iwama, M. Koike, 1994, Cancer research.

Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis.

T. Iwama, K. Tanaka, M. Miyaki, 1993, Cancer research.

Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.

H. Lenz, K. Danenberg, P. Danenberg, 2008, International Journal of Oncology.

The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis.

T. Iwama, J. Utsunomiya, M. Miyaki, 2000, Japanese journal of clinical oncology.

Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis.

M. Yasuno, S. Iida, K. Sugihara, 2011, Oncology reports.